Loading…

Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy

Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multice...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2017-07, Vol.189, p.75-84
Main Authors: Perini, Alessandro Paoletti, Kutyifa, Valentina, Veazie, Peter, Daubert, James P., Schuger, Claudio, Zareba, Wojciech, McNitt, Scott, Rosero, Spencer, Tompkins, Christine, Padeletti, Luigi, Moss, Arthur J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953
cites cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953
container_end_page 84
container_issue
container_start_page 75
container_title The American heart journal
container_volume 189
creator Perini, Alessandro Paoletti
Kutyifa, Valentina
Veazie, Peter
Daubert, James P.
Schuger, Claudio
Zareba, Wojciech
McNitt, Scott
Rosero, Spencer
Tompkins, Christine
Padeletti, Luigi
Moss, Arthur J.
description Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates. In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P .05). In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.
doi_str_mv 10.1016/j.ahj.2017.03.009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911199480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870317300923</els_id><sourcerecordid>1922855920</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</originalsourceid><addsrcrecordid>eNp9kc1u1DAQgC0EotvCA3BBlrhwSWonjp3AadUfWKkVElrOlmOPWYdsvLWdin2CvjbebuHAoYexx_I3458PoXeUlJRQfj6UajOUFaGiJHVJSPcCLSjpRMEFYy_RghBSFa0g9Qk6jXHIS161_DU6yWPV1C1boIcra0GniL3Fbrsb1ZRUPwLWKhjn7yEkCOcGrOuDG0eVfMBx4_UvrCaTI7mk9Gb_SCu8U9pNP7Gf8s5vB2n_SN3NanQ5zyeMzsInvMS3y8vVuvi-WuM49zHNZv8GvbJqjPD2aT5DP66v1hdfi5tvX1YXy5tCMyZSQa3pSUs11cpW0LIaGK9FDm4aBn3Td7atCaeUc8ZAMAqEE8sqK6gQddfUZ-jjse8u-LsZYpJbFzXkp03g5yhpRyntOtaSjH74Dx38HKZ8u0xVVds0XXWg6JHSwccYwMpdcFsV9pISebAkB5ktyYMlSWqZLeWa90-d534L5l_FXy0Z-HwEIH_FvYMgo3YwaTAuZFvSePdM-z_RNKHm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922855920</pqid></control><display><type>article</type><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</creator><creatorcontrib>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</creatorcontrib><description>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates. In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P&lt;.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values &gt; .05). In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2017.03.009</identifier><identifier>PMID: 28625384</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anxiety ; Anxiety - etiology ; Anxiety - psychology ; Cardiac arrhythmia ; Councils ; Defibrillators ; Defibrillators, Implantable ; Electric Countershock - instrumentation ; Female ; Follow-Up Studies ; Heart attacks ; Heart failure ; Humans ; Implantation ; Male ; Middle Aged ; Mortality ; Patients ; Quality of Life ; Questionnaires ; Risk Factors ; Shock ; Surveys and Questionnaires ; Tachycardia, Ventricular - complications ; Tachycardia, Ventricular - psychology ; Tachycardia, Ventricular - therapy ; Therapy ; Time Factors ; Transplants &amp; implants ; Treatment Outcome ; Women</subject><ispartof>The American heart journal, 2017-07, Vol.189, p.75-84</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</citedby><cites>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28625384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perini, Alessandro Paoletti</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><creatorcontrib>Veazie, Peter</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Schuger, Claudio</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Tompkins, Christine</creatorcontrib><creatorcontrib>Padeletti, Luigi</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates. In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P&lt;.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values &gt; .05). In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</description><subject>Anxiety</subject><subject>Anxiety - etiology</subject><subject>Anxiety - psychology</subject><subject>Cardiac arrhythmia</subject><subject>Councils</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable</subject><subject>Electric Countershock - instrumentation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Implantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Risk Factors</subject><subject>Shock</subject><subject>Surveys and Questionnaires</subject><subject>Tachycardia, Ventricular - complications</subject><subject>Tachycardia, Ventricular - psychology</subject><subject>Tachycardia, Ventricular - therapy</subject><subject>Therapy</subject><subject>Time Factors</subject><subject>Transplants &amp; implants</subject><subject>Treatment Outcome</subject><subject>Women</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAQgC0EotvCA3BBlrhwSWonjp3AadUfWKkVElrOlmOPWYdsvLWdin2CvjbebuHAoYexx_I3458PoXeUlJRQfj6UajOUFaGiJHVJSPcCLSjpRMEFYy_RghBSFa0g9Qk6jXHIS161_DU6yWPV1C1boIcra0GniL3Fbrsb1ZRUPwLWKhjn7yEkCOcGrOuDG0eVfMBx4_UvrCaTI7mk9Gb_SCu8U9pNP7Gf8s5vB2n_SN3NanQ5zyeMzsInvMS3y8vVuvi-WuM49zHNZv8GvbJqjPD2aT5DP66v1hdfi5tvX1YXy5tCMyZSQa3pSUs11cpW0LIaGK9FDm4aBn3Td7atCaeUc8ZAMAqEE8sqK6gQddfUZ-jjse8u-LsZYpJbFzXkp03g5yhpRyntOtaSjH74Dx38HKZ8u0xVVds0XXWg6JHSwccYwMpdcFsV9pISebAkB5ktyYMlSWqZLeWa90-d534L5l_FXy0Z-HwEIH_FvYMgo3YwaTAuZFvSePdM-z_RNKHm</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Perini, Alessandro Paoletti</creator><creator>Kutyifa, Valentina</creator><creator>Veazie, Peter</creator><creator>Daubert, James P.</creator><creator>Schuger, Claudio</creator><creator>Zareba, Wojciech</creator><creator>McNitt, Scott</creator><creator>Rosero, Spencer</creator><creator>Tompkins, Christine</creator><creator>Padeletti, Luigi</creator><creator>Moss, Arthur J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><author>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anxiety</topic><topic>Anxiety - etiology</topic><topic>Anxiety - psychology</topic><topic>Cardiac arrhythmia</topic><topic>Councils</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable</topic><topic>Electric Countershock - instrumentation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Implantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Risk Factors</topic><topic>Shock</topic><topic>Surveys and Questionnaires</topic><topic>Tachycardia, Ventricular - complications</topic><topic>Tachycardia, Ventricular - psychology</topic><topic>Tachycardia, Ventricular - therapy</topic><topic>Therapy</topic><topic>Time Factors</topic><topic>Transplants &amp; implants</topic><topic>Treatment Outcome</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perini, Alessandro Paoletti</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><creatorcontrib>Veazie, Peter</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Schuger, Claudio</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Tompkins, Christine</creatorcontrib><creatorcontrib>Padeletti, Luigi</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perini, Alessandro Paoletti</au><au>Kutyifa, Valentina</au><au>Veazie, Peter</au><au>Daubert, James P.</au><au>Schuger, Claudio</au><au>Zareba, Wojciech</au><au>McNitt, Scott</au><au>Rosero, Spencer</au><au>Tompkins, Christine</au><au>Padeletti, Luigi</au><au>Moss, Arthur J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2017-07</date><risdate>2017</risdate><volume>189</volume><spage>75</spage><epage>84</epage><pages>75-84</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><abstract>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates. In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P&lt;.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values &gt; .05). In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28625384</pmid><doi>10.1016/j.ahj.2017.03.009</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2017-07, Vol.189, p.75-84
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_1911199480
source ScienceDirect Freedom Collection 2022-2024
subjects Anxiety
Anxiety - etiology
Anxiety - psychology
Cardiac arrhythmia
Councils
Defibrillators
Defibrillators, Implantable
Electric Countershock - instrumentation
Female
Follow-Up Studies
Heart attacks
Heart failure
Humans
Implantation
Male
Middle Aged
Mortality
Patients
Quality of Life
Questionnaires
Risk Factors
Shock
Surveys and Questionnaires
Tachycardia, Ventricular - complications
Tachycardia, Ventricular - psychology
Tachycardia, Ventricular - therapy
Therapy
Time Factors
Transplants & implants
Treatment Outcome
Women
title Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T20%3A48%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20implantable%20cardioverter/defibrillator%20shock%20and%20antitachycardia%20pacing%20on%20anxiety%20and%20quality%20of%20life:%20A%20MADIT-RIT%20substudy&rft.jtitle=The%20American%20heart%20journal&rft.au=Perini,%20Alessandro%20Paoletti&rft.date=2017-07&rft.volume=189&rft.spage=75&rft.epage=84&rft.pages=75-84&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/j.ahj.2017.03.009&rft_dat=%3Cproquest_cross%3E1922855920%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1922855920&rft_id=info:pmid/28625384&rfr_iscdi=true